628P Development of a CRISPR/CasX 4q telomeric region ablation strategy for FSHD1 using an isogenic hiPSC line and a FSHD1 fibroblast cell line by Lama, C., de Graaf, N., Akar, R. Bou, Danaus, P., Suel-Petat, L., Nectoux, J., Authier, F., Relaix, F., Richard, I., Malfatti, E.

Get full text